Altus Copper Applies for Partial Revocation of Failure-to-File Cease Trade Order, Announces Proposed Financing and Provides Further Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - Altus Copper Corp. (the "Company") announces that it has applied to the British Columbia Securities Commission (the "BCSC") and the Ontario Securities Commission (the "OSC") for a partial revocation order (the "Partial Revocation Order") of the failure-to-file cease trade order jointly issued by the BCSC and the OSC on December 5, 2023 (the "FFCTO"). The Company further announces a proposed fina
Food / Beverages, Healthcare and Hospitals, Health
2026-06-17 5:30 PM EDT | Altus Copper Corp.
WELL Health Announces Voting Results for Election of Directors
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that at its annual general and special meeting held June 16, 2026 (the "Meeting"), all of the nominees for election as directors of the Compa
Technology, Computer Software, Healthcare and Hospitals, Health
2026-06-17 7:00 AM EDT | WELL Health Technologies Corp.
HEALWELL AI Provides Corporate Update: Multi-Province AI Pilot Results Accepted at AMIA Symposium; Alongside Balance Sheet Strengthening with SpaceX Holdings
HEALWELL successfully completed a pilot evaluating its DARWEN™ AI powered SMART Summary™ and SMART Search™ solutions in multiple provinces across Canada. The pilot demonstrated how clinically validated and interoperable AI can reduce chart review burden, improve access to patient information and support more efficient clinical workflows. HEALWELL is exploring opportunities to expand deployment of its SMART products across additional h
Technology, Healthcare and Hospitals
2026-06-17 3:15 AM EDT | HEALWELL AI
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call
Ontario and Chicago, Illinois--(Newsfile Corp. - June 16, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Friday, June 26, 2026 to discuss Medexus's results for its fourth fiscal quarter and fiscal year ended March 31, 2026. Medexus expects to file its financial statements and MD&A after markets close on June 25, 2026. To participate in the call, please dial the following numbers:
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-16 5:30 PM EDT | Medexus Pharmaceuticals Inc.
Adia Med Improves Quality of Care with Advanced Ultrasound-Guided IV Training
Winter Park, Florida--(Newsfile Corp. - June 16, 2026) - Adia Med, the regenerative medicine and advanced IV therapy division of Adia Nutrition Inc. (OTCQB: ADIA), today announced a major step forward in patient care quality. Renowned physician Dr. Brian Browning, DO, Lead Physician at Adia Med, will personally train the company's Advanced Practice Registered Nurses (APRNs) and Registered Nurses (RNs) in ultrasound-guided intravenous (IV) insertions and administrations using the innovative Bu
Healthcare and Hospitals, Health
2026-06-16 10:55 AM EDT | Adia Nutrition Inc.
TelyRx Announces Voting Results from Annual General Meeting of Shareholders
Clearwater, Florida--(Newsfile Corp. - June 15, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, announced today that each of the following nominees proposed to be elected at the Annual Meeting of Shareholders held on Monday, June 15, 2026 (the "Meeting"), has been elected. In addition, the other resolution put to vote at the Meeting was passed.
Healthcare and Hospitals, Health
2026-06-15 6:57 PM EDT | TelyRx
Extendicare Announces June 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - June 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of June 2026, which is payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare i
Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-15 8:00 AM EDT | Extendicare Inc.
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Northvale, New Jersey--(Newsfile Corp. - June 15, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products, today reported positive results from a pivotal bioequivalence study for an undisclosed anticonvulsant generic drug product. IQVIA reported branded and generic product sales for the twelve months ending April 2026 of $840 million.
Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-15 7:00 AM EDT | Elite Pharmaceuticals, Inc.
Cosmo Welcomes the Launches of Winlevi(R) in Austria and Germany
Ireland and Heppenheim, Germany--(Newsfile Corp. - June 15, 2026) - Cosmo N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is pleased to announce the launch of its innovative acne cream Winlevi® (clascoterone 1% cream) in Austria and Germany by its commercial partner InfectoPharm Arzneimittel und Consilium GmbH (“InfectoPharm”). Winlevi® is available in both countries since June 1. Cosmo is the exclusive manufacturer of the product.
Healthcare and Hospitals, Health
2026-06-15 1:01 AM EDT | Cosmo Pharmaceuticals N.V.
Bachem Holding AG Announces Capital Markets Day 2026
Bubendorf, Switzerland--(Newsfile Corp. - June 12, 2026) - Bachem Holding AG (SIX: BANB) will host its Capital Markets Day on 26 November 2026 at The Circle Convention Center, Hyatt Regency Zurich Airport, as well as virtually. This hybrid event will provide insights into the company's strategic priorities, business outlook, and key developments.
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2026-06-12 11:47 AM EDT | Bachem Holding AG
Healthcare Special Opportunities Fund Announces June 2026 Quarterly Distribution
Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - LDIC Inc. (the "Manager"), the manager of Healthcare Special Opportunities Fund (TSX: MDS.UN) (the "Fund"), a closed-end investment fund, today announces the quarterly distribution of CDN$0.05923 per Class A unit and US$0.05261 per Class U unit. The distribution will be paid on or before July 10, 2026, to unitholders of record on June 30, 2026. For further information pleas
Banking / Financial Services, Healthcare and Hospitals
2026-06-12 10:29 AM EDT | Healthcare Special Opportunities Fund
Senior Care Authority Releases Father's Day Guide with 10 Warning Signs that Aging Parents Need Support
Incline Village, Nevada--(Newsfile Corp. - June 12, 2026) - Senior Care Authority shares insights on Father’s Day visits, highlighting how the occasion can help families notice when aging parents may be struggling in ways not visible from a distance. "Holiday visits are often when families first notice something has changed," said Frank Samson, founder and CEO of Senior Care Authority. "It's not always dramatic. Sometimes it's a messy kitchen or a conversation that feels sli
Healthcare and Hospitals, Health
2026-06-12 9:00 AM EDT | Senior Care Authority
WELL Health Provides a Corporate Update on Circle Medical
WELL Health is providing a corporate update on its majority-owned subsidiary Circle Medical, a leading telehealth platform delivering accessible, insurance-based primary care across the United States. Circle Medical continues to expand access to care, having more than tripled the number of commercially insured patients eligible to receive care on its platform over the last year, supported by strong double-digit growth in new patient bookings and activations in May 2026 as compare
Technology, Computer Software, Healthcare and Hospitals, Health
2026-06-12 7:00 AM EDT | WELL Health Technologies Corp.
Cosmo Welcomes the Launch of Winlevi(R) in Key European Markets by Its Partner Glenmark
Dublin, Ireland--(Newsfile Corp. - June 11, 2026) - Cosmo N.V. (SIX: COPN) (XETRA: C43) (“Cosmo”) is pleased to make known that its commercial partner Glenmark Specialty S.A (GSSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd., today announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the tr
Healthcare and Hospitals, Health
2026-06-11 1:19 AM EDT | Cosmo Pharmaceuticals N.V.
Adia Nutrition Inc. Delivers Exciting Update: Name Change to Adia Med Inc. Now Official in Nevada
Winter Park, Florida--(Newsfile Corp. - June 10, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is pleased to confirm that the State of Nevada has officially approved the company's name change to Adia Med Inc.
Healthcare and Hospitals, Health
2026-06-10 9:15 AM EDT | Adia Nutrition Inc.
Aurora Spine Grants Stock Options
Carlsbad, California--(Newsfile Corp. - June 9, 2026) - Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF) ("Aurora Spine" or the "Company"), a leader in the development of groundbreaking medical devices for spinal surgery, today announced that it has granted stock options (the "Options") to acquire 2,020,000 common shares of the Company. A total of 1,300,000 were granted to members of the Company's Board of Directors and the balance to certain employees of the Compa
2026-06-09 6:07 PM EDT | Aurora Spine Corporation
Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada
Ontario and Chicago, Illinois--(Newsfile Corp. - June 9, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF)
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-09 5:30 PM EDT | Medexus Pharmaceuticals Inc.
BioMark Secures Broad U.S. Patent for Urine-Based Lung Cancer Screening, Expanding Differentiated Liquid Biopsy Testing Platform
Vancouver, British Columbia--(Newsfile Corp. - June 9, 2026) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy technologies for early cancer detection, is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a Notice of Patent Allowance for Application No. 18/304,741, titled "Method of Detecting Lung Cancer." The allowed patent covers the proprietary use of ur
Technology, Biotechnology, Healthcare and Hospitals
2026-06-09 8:30 AM EDT | BioMark Diagnostics, Inc.
Altus Copper Provides Corporate Updates
Vancouver, British Columbia--(Newsfile Corp. - June 8, 2026) - Altus Copper Corp. (the "Company") is pleased to provide a summary of several board and management changes undertaken over the past 18 months. On March 18, 2025, Zayn Kalyan resigned as Chief Executive Officer and a director of the Company. The Company does not currently have a CEO, although Arndt Roehlig was engaged as President on March 18, 2025. On August 8, 2025, Jason Baker was appointed as Chief Financial
Food / Beverages, Healthcare and Hospitals, Health
2026-06-08 9:15 PM EDT | Altus Copper Corp.
Adia Nutrition Launches Dynamic New Subsidiary ADIA Life LLC in Florida to Supercharge Distribution and Unlock a Full Spectrum of Life-Transforming Wellness Solutions
Winter Park, Florida--(Newsfile Corp. - June 8, 2026) - Adia Nutrition (OTCQB: ADIA), a leader in advanced nutrition and regenerative health products, today announced the official launch of its new wholly-owned subsidiary, ADIA Life LLC, headquartered in the state of Florida.
Healthcare and Hospitals, Health
2026-06-08 12:51 PM EDT | Adia Nutrition Inc.